Cite Filings / GANX / 9999999995-22-001659

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Gain Therapeutics, Inc. Filed 2022-06-01 Acc 9999999995-22-001659

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2023-12-29 EFFECT Notice of Effectiveness
2022-06-01 EFFECT Notice of Effectiveness
2022-05-31 CORRESP Correspondence Between Filers and SEC Staff
2022-05-27 4 CHIEF EXECUTIVE OFFICER bought 2,482 shares at $2.58 ($6,404)
2021-03-17 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…